GlassScriptPhysician profile
Kara B Sigler
NPI 1548813017
$962.89
in general payments reported to CMS, 2019-2025
21 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $259 · 2023: $214 · 2024: $184 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $155.98 | 2021-2024 | Epclusa |
| Abbvie INC. | $143.31 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $78.42 | 2022 | |
| Lilly USA, LLC | $65.30 | 2022-2023 | Mounjaro |
| Astellas Pharma US INC | $62.20 | 2024 | Veozah |
| Biohaven Pharmaceuticals, INC. | $62.07 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $56.13 | 2022-2023 | Rexulti |
| Exact Sciences Corporation | $39.51 | 2023 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $37.64 | 2025 | Fanapt, Hetlioz |
| Amgen INC. | $31.19 | 2022-2025 | Evenity, Prolia |
| Novo Nordisk INC | $29.87 | 2023 | Wegovy, Ozempic, Rybelsus |
| Aimmune Therapeutics, INC. | $28.82 | 2025 | Vowst |
| Hologic Sales and Service, LLC | $25.41 | 2025 | Aptima |
| Daiichi Sankyo INC. | $24.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.02 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $18.97 | 2025 | Korlym |
| Intercept Pharmaceuticals, INC. | $18.92 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.46 | 2022 | |
| Pfizer INC. | $17.81 | 2023 | |
| Irhythm Technologies, INC. | $14.91 | 2024 | Zio Monitor, Zio Xt Patch |
| Idorsia Pharmaceuticals US INC | $13.00 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Sigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.